Cancer glossary
AFP (alpha-fetoprotein): when this tumor marker is raised and what it means
AFP is a tumor marker used in liver cancer and germ cell tumors of the testis and ovary. Why a raised result doesn't equal cancer and how doctors use the trend.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 19 October 2026
In short
AFP (alpha-fetoprotein) is a protein normally made by a fetus. In adults the level is low. A high AFP can occur in liver cancer (hepatocellular carcinoma) and some germ cell tumors of the testis and ovary.
How it appears in your report
- ‘AFP 3.2 IU/mL (normal up to 10)’.
- ‘AFP 850 ng/mL’ — a marked rise.
- ‘AFP, hCG, LDH’ — the marker set for germ cell tumors.
What it means
According to the US National Cancer Institute, AFP is used in liver cancer, ovarian cancer and germ cell tumors — to help with diagnosis and to follow the response to treatment. In germ cell tumors of the testis, marker levels are also taken into account when staging.
AFP also rises with hepatitis, cirrhosis and pregnancy. So one raised result is a reason for tests, not a diagnosis. The trend matters more: a rise from one test to the next means more than a single number. It is better to compare results from the same lab — labs differ in methods and reference ranges.
Does it affect treatment
Not on its own. Treatment is chosen from CT/MRI and pathology. AFP helps track the effect: a fall after surgery or chemotherapy is a good sign, a renewed rise is a reason for an unscheduled scan.
Questions to ask your doctor
- What was my AFP before treatment, and what target are we expecting?
- How often should I have it checked?
- What will we do if it starts to rise?
Sources
- Tumor Markers in Common Use — National Cancer Institute
- Tumor Markers — National Cancer Institute
FAQ
Related terms
This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.
